Tips

三月美迪西將主辦3場(chǎng)線上直播，同時(shí)參與2場(chǎng)國(guó)內(nèi)外會(huì)議，期待與各位業(yè)內(nèi)同仁交流分享藥物研發(fā)新趨勢(shì)。

易貿(mào)2025 BIOCHINA

BIO CHINA 2025第十屆易貿(mào)生物產(chǎn)業(yè)展覽將于3月13-15日在蘇州國(guó)際博覽中心隆重開幕。

美迪西創(chuàng)始人、董事長(zhǎng)兼CEO陳春麟博士將出席14日?qǐng)A桌討論：校企合作，共建創(chuàng)新生態(tài)圈。美迪西毒理研究部副總裁曾憲成博士將出席14日美迪西頭腦風(fēng)暴專場(chǎng)，并發(fā)表主題演講。

美迪西團(tuán)隊(duì)將在C館：C3-120號(hào)展位，等待您的蒞臨交流！

SOT 64th Annual Meeting and ToxExpo 

Medicilon is excited to exhibit at SOT 2025 in Orlando (Medicilon Booth #1416).Dr. Lilly Xu (CTO of Medicilon)and Dr. Hanjun Zou (TFM of Medicilon Chuansha Site) will be available at the booth. Dr. Xu specializes in pharmacokinetics, toxicology, and drug metabolism, while Dr. Zou brings nearly 20 years of experience in toxicity and preclinical safety assessment.

Medicilon's state-of-the-art preclinical facilities hold full AAALAC accreditation. With advanced platforms and experienced scientists, Medicilon guarantees the utmost professionalism in drug efficacy and safety assessments services, adhering to global regulatory standards. Offering services from stand-alone preclinical studies to comprehensive IND-enabling packages, Medicilon provides flexible solutions to efficiently support biotech and pharmaceutical clients in reaching their developmental milestones.

marketing@medicilon.com.
媒體與會(huì)務(wù)請(qǐng)聯(lián)系
美迪西市場(chǎng)部微信或郵箱